News
Introduction
Overexpression of cyclooxegenase-2 (COX-2) is a hallmark of inflammation and an early event in carcinogenesis and cancer progression.1,2 Because COX-2 is expressed in virtually all solid tumors, it represents an ideal biomarker with broad impact for the early clinical detection of…
Vinod LabhasetwarAt the DDTR editorial board meeting held during the CRS annual meeting in Seattle, I updated several parameters related to the journal and presented my vision for further growth. The most significant news was a 130% increase in citations compared with the year ending July 2015.…
The 10th annual meeting of the CRS Israeli Local Chapter (ICRS), “20 Years of Excellent Research and Translation,” was held in Maalot, in the north of Israel, on September
From left to right: Yechezkel (Chezy) Barenholz (Hebrew University), Phil Low (Purdue University), Alan Packard (Harvard…
MyCRS president Mohd Cairul Iqbal Mohd Amin presents the best poster award to Benchawan Chamsai.The CRS Malaysia Local Chapter (MyCRS) took part in Pharma+BioAsia 2016 as a Knowledge Partner. The meeting was held September 28–29 at the Kuala Lumpur Convention Centre, Kuala Lumpur, Malaysia. MyCRS’s…
This article briefly summarizes novel aspects of selected United States (U.S.) patents involving controlled release or delivery that were issued from January 1 to June 30, 2016. Patents are loosely categorized into selected subject areas, but most have potentially broader applicability. Greater…
Ali KhademhosseiniProf. Ali Khademhosseini is a professor of biomedical engineering and medicine at Harvard Medical School and a faculty member at the Harvard–Massachusetts Institute of Technology (MIT) Division of Health Science and Technology and at Brigham and Women’s Hospital, as well as an…
